Navegar por autor "Mel Lorenzo, José Ramón"

Mostrando ítems 1-11 de 11

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

2011- Antolín Novoa, Silvia; García Mata, Jesús; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón; De Paz Arias , Laura [et al.]
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis

2011- Mel Lorenzo, José Ramón; Villanueva Millán, María Jesús
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

2013- Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; Campos Balea, Begoña; Álvarez Gómez, Elena; Quintero Aldana, Guillermo; [et al.]
Clinical value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative ...

2011- Mel Lorenzo, José Ramón
Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón [et al.]
Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

2011- Firvida Perez, Jose Luis; Fernández Montes, Ana; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.

2011- Mel Lorenzo, José Ramón; Villanueva Silva, María José
Maintenance treatment with cetuximab in a series of patients treated with standard chemotherapy and cetuximab in metastatic colorectal cancer

2011- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Quintero Aldana, Guillermo; Mel Lorenzo, José Ramón; [et al.]
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study

2011- Mel Lorenzo, José Ramón
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.

2011- Mel Lorenzo, José Ramón
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; Quintero Aldana, Guillermo; [et al.]